|
Accession number;04A0146760
|
| Title;HIGH DOSE RATE INTERSTITIAL BRACHYTHERAPY FOR OROPHARYNX CANCER |
| Author;
NOSE TAKAYUKI
(Center for Adult Dis., Osaka)
KOIZUMI MASAHIKO
(Center for Adult Dis., Osaka)
NISHIYAMA KINJI
(Center for Adult Dis., Osaka)
YOSHIDA KEN
(Osaka National Hospital, JPN)
INOUE TOSHIHIKO
(Osakadai Shugakuhoshasenchiryogaku)
|
Journal Title;Head and Neck Cancer
|
Journal Code:Y0503A
|
ISSN:0911-4335
|
|
VOL.28;NO.1;PAGE.198-204(2002)
|
| Figure&Table&Reference;FIG.5, TBL.4, REF.31 |
| Pub. Country;Japan |
| Language;Japanese |
| Abstract;To improve local control of oropharynx squamous cell carcinoma and to lessen radiation sequelae by definitive external beam, high dose rate interstitial brachytherapy as a combined therapy or as a monotherapy was begun in 1993. Achieved were 85.1% of the five-year local control rate for 47 lesions in the 46 patients. Five-year cause specific and overall survival rates were 84.5% and 62.6% (minimum/maximum/median/mean follow-up were 1/88/22/30 months, respectively). Transient ulcer was observed in 38.3%. Compared to definitive external beam radiotherapy series, better local control was achieved. Compared to low-dose rate interstitial series, local control and complications were almost equivalent. This treatment modality was considerably superior to external beam radiotherapy in terms of local control. As a clinical impression, xerostomia and taste loss seemed greatly improved. (author abst.) |
|
|
|
Related Articles;
|
